HYPR
Hyperfine, Inc.
Medical Devices · Healthcare · United States
0.72
close · 2026-10-30
value
4
cheaper than peers4
quality
37
stronger fundamentals37
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 2.07× | 65 |
| price to sales | 4.60× | 29 |
| earnings yield, 2 years ago | -86.4% | 18 |
| cash flow yield, 1 year ago | -51.4% | 15 |
| earnings yield, latest year | -59.9% | 13 |
| cash flow yield, latest year | -38.3% | 13 |
| earnings yield, 3 years ago | -144.9% | 12 |
| earnings yield, 1 year ago | -78.0% | 12 |
| cash flow yield, 2 years ago | -56.0% | 10 |
| cash flow yield, 3 years ago | -95.8% | 8 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 44.8% | 96 |
| debt to equity | 36.5% | 55 |
| return on equity | -97.0% | 19 |
| operating margin | -216.9% | 7 |
4 of 4 measures available
Facts
| market cap | $76M |
| free cash flow | -$17.2M |
| employees | 102 |
| first trade | 2021-01-28 |
| next earnings | 2026-11-09 |
| fundamentals updated | 2026-08-19 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.43 | -0.56 | -0.62 | -1.04 |
| free cash flow | -$29.1M | -$39.1M | -$42.6M | -$72.9M |
| net income | -$35.6M | -$40.7M | -$44.2M | -$73.2M |
| revenue | $13.6M | $12.9M | $11.0M | $6.8M |
| unusual items | $825,000 | not reported | not reported | not reported |